BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27135533)

  • 1. Mapping the Spectrum of Gene Expression Responses.
    Pargett M; Albeck JG
    Cell Syst; 2016 Apr; 2(4):221-2. PubMed ID: 27135533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations.
    Jiménez A; Lu D; Kalocsay M; Berberich MJ; Balbi P; Jambhekar A; Lahav G
    Mol Syst Biol; 2022 Mar; 18(3):e10588. PubMed ID: 35285572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
    Millau JF; Bastien N; Bouchard EF; Drouin R
    Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past Roadblocks and New Opportunities in Transcription Factor Network Mapping.
    Brent MR
    Trends Genet; 2016 Nov; 32(11):736-750. PubMed ID: 27720190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 induction prevents accumulation of aberrant transcripts in cancer cells.
    Moyret-Lalle C; Duriez C; Van Kerckhove J; Gilbert C; Wang Q; Puisieux A
    Cancer Res; 2001 Jan; 61(2):486-8. PubMed ID: 11212237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer. p53, guardian of the genome.
    Lane DP
    Nature; 1992 Jul; 358(6381):15-6. PubMed ID: 1614522
    [No Abstract]   [Full Text] [Related]  

  • 7. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Tcf-4 as a transcriptional target of p53 signalling.
    Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K
    Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global map of p53 transcription-factor binding sites in the human genome.
    Wei CL; Wu Q; Vega VB; Chiu KP; Ng P; Zhang T; Shahab A; Yong HC; Fu Y; Weng Z; Liu J; Zhao XD; Chew JL; Lee YL; Kuznetsov VA; Sung WK; Miller LD; Lim B; Liu ET; Yu Q; Ng HH; Ruan Y
    Cell; 2006 Jan; 124(1):207-19. PubMed ID: 16413492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F3-a novel repressor of the ARF/p53 pathway.
    Ginsberg D
    Dev Cell; 2004 Jun; 6(6):742-3. PubMed ID: 15177020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar Domains for Different Regulations of p53 Family.
    Amelio I; Melino G
    Structure; 2018 Aug; 26(8):1047-1049. PubMed ID: 30089247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts.
    Kim H; You S; Kim IJ; Foster LK; Farris J; Ambady S; Ponce de León FA; Foster DN
    Oncogene; 2001 May; 20(21):2671-82. PubMed ID: 11420679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential transcriptional activation element in the p53 protein.
    O'Rourke RW; Miller CW; Kato GJ; Simon KJ; Chen DL; Dang CV; Koeffler HP
    Oncogene; 1990 Dec; 5(12):1829-32. PubMed ID: 2284102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells.
    Das A; Chai JC; Jung KH; Das ND; Kang SC; Lee YS; Seo H; Chai YG
    Exp Cell Res; 2014 Nov; 328(2):361-78. PubMed ID: 25193078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.